Clinical, Biochemical, and Radiological Profile of Normocalcemic Primary Hyperparathyroidism
Abstract Context The clinical and radiological aspects of normocalcemic hyperparathyroidism (NHPT) are confounded by the differing methods used to rule out secondary hyperparathyroidism and by the small sample size. Objective To assess the clinical, biochemical, and radiological profile of NHPT comp...
Saved in:
Published in | The journal of clinical endocrinology and metabolism Vol. 105; no. 7; pp. e2609 - e2616 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
US
Oxford University Press
01.07.2020
Copyright Oxford University Press |
Subjects | |
Online Access | Get full text |
ISSN | 0021-972X 1945-7197 1945-7197 |
DOI | 10.1210/clinem/dgaa174 |
Cover
Abstract | Abstract
Context
The clinical and radiological aspects of normocalcemic hyperparathyroidism (NHPT) are confounded by the differing methods used to rule out secondary hyperparathyroidism and by the small sample size.
Objective
To assess the clinical, biochemical, and radiological profile of NHPT compared with primary hyperparathyroidism (PHPT) and control subjects
Design
Multicentric cross-sectional study
Setting
Outpatient clinic
Patients
47 NHPT, 41 PHPT, and 39 age- and sex-matched control subjects.
Main Outcome Measures
Calcium metabolism and bone turnover markers (BTMs). Lumbar spine, total hip, femoral neck, one-third distal radius bone mineral density (BMD). Morphometric vertebral fracture (VF) assessed by dual-energy X-ray absorptiometry.
Results
NHPT patients had significantly higher parathyroid hormone, 25(OH)-vitamin D levels and lower calcium × phosphorus product than controls (P < .001). Compared with PHPT, the NHPT group had significantly higher 25(OH) vitamin D levels (P = .016). NHPT had BTM levels similar to controls and PHPT. NHPT, PHPT, and controls have similar lumbar spine and femoral neck BMD. NHPT and controls had a similar radial BMD, while patients with PHPT had a lower radial BMD than both patients with NHPT (P = .031) and controls (P < .05). Using the control group as the reference, after adjustment for interacting factors, there was no increase in risk of moderate–severe VF in NHPT (odds ratio [OR] 1.04, 95% confidence interval [CI] 0.25-4.55), while PHPT had an increased risk (OR 3.81,95% CI 1.15-15.12). Seventy-nine percent of NHPT and 59% of PHPT patients fulfilled the criteria for asymptomatic hyperparathyroidism.
Conclusions
The biochemical phenotype of NHPT is intermediate between PHPT and controls. In contrast, the bone phenotype resembles controls with normal bone turnover, no significant BMD impairment, and no increased risk of VF. |
---|---|
AbstractList | The clinical and radiological aspects of normocalcemic hyperparathyroidism (NHPT) are confounded by the differing methods used to rule out secondary hyperparathyroidism and by the small sample size.
To assess the clinical, biochemical, and radiological profile of NHPT compared with primary hyperparathyroidism (PHPT) and control subjects.
Multicentric cross-sectional study.
Outpatient clinic.
47 NHPT, 41 PHPT, and 39 age- and sex-matched control subjects.
Calcium metabolism and bone turnover markers (BTMs). Lumbar spine, total hip, femoral neck, one-third distal radius bone mineral density (BMD). Morphometric vertebral fracture (VF) assessed by dual-energy X-ray absorptiometry.
NHPT patients had significantly higher parathyroid hormone, 25(OH)-vitamin D levels and lower calcium × phosphorus product than controls (P < .001). Compared with PHPT, the NHPT group had significantly higher 25(OH) vitamin D levels (P = .016). NHPT had BTM levels similar to controls and PHPT. NHPT, PHPT, and controls have similar lumbar spine and femoral neck BMD. NHPT and controls had a similar radial BMD, while patients with PHPT had a lower radial BMD than both patients with NHPT (P = .031) and controls (P < .05). Using the control group as the reference, after adjustment for interacting factors, there was no increase in risk of moderate-severe VF in NHPT (odds ratio [OR] 1.04, 95% confidence interval [CI] 0.25-4.55), while PHPT had an increased risk (OR 3.81,95% CI 1.15-15.12). Seventy-nine percent of NHPT and 59% of PHPT patients fulfilled the criteria for asymptomatic hyperparathyroidism.
The biochemical phenotype of NHPT is intermediate between PHPT and controls. In contrast, the bone phenotype resembles controls with normal bone turnover, no significant BMD impairment, and no increased risk of VF. The clinical and radiological aspects of normocalcemic hyperparathyroidism (NHPT) are confounded by the differing methods used to rule out secondary hyperparathyroidism and by the small sample size.CONTEXTThe clinical and radiological aspects of normocalcemic hyperparathyroidism (NHPT) are confounded by the differing methods used to rule out secondary hyperparathyroidism and by the small sample size.To assess the clinical, biochemical, and radiological profile of NHPT compared with primary hyperparathyroidism (PHPT) and control subjects.OBJECTIVETo assess the clinical, biochemical, and radiological profile of NHPT compared with primary hyperparathyroidism (PHPT) and control subjects.Multicentric cross-sectional study.DESIGNMulticentric cross-sectional study.Outpatient clinic.SETTINGOutpatient clinic.47 NHPT, 41 PHPT, and 39 age- and sex-matched control subjects.PATIENTS47 NHPT, 41 PHPT, and 39 age- and sex-matched control subjects.Calcium metabolism and bone turnover markers (BTMs). Lumbar spine, total hip, femoral neck, one-third distal radius bone mineral density (BMD). Morphometric vertebral fracture (VF) assessed by dual-energy X-ray absorptiometry.MAIN OUTCOME MEASURESCalcium metabolism and bone turnover markers (BTMs). Lumbar spine, total hip, femoral neck, one-third distal radius bone mineral density (BMD). Morphometric vertebral fracture (VF) assessed by dual-energy X-ray absorptiometry.NHPT patients had significantly higher parathyroid hormone, 25(OH)-vitamin D levels and lower calcium × phosphorus product than controls (P < .001). Compared with PHPT, the NHPT group had significantly higher 25(OH) vitamin D levels (P = .016). NHPT had BTM levels similar to controls and PHPT. NHPT, PHPT, and controls have similar lumbar spine and femoral neck BMD. NHPT and controls had a similar radial BMD, while patients with PHPT had a lower radial BMD than both patients with NHPT (P = .031) and controls (P < .05). Using the control group as the reference, after adjustment for interacting factors, there was no increase in risk of moderate-severe VF in NHPT (odds ratio [OR] 1.04, 95% confidence interval [CI] 0.25-4.55), while PHPT had an increased risk (OR 3.81,95% CI 1.15-15.12). Seventy-nine percent of NHPT and 59% of PHPT patients fulfilled the criteria for asymptomatic hyperparathyroidism.RESULTSNHPT patients had significantly higher parathyroid hormone, 25(OH)-vitamin D levels and lower calcium × phosphorus product than controls (P < .001). Compared with PHPT, the NHPT group had significantly higher 25(OH) vitamin D levels (P = .016). NHPT had BTM levels similar to controls and PHPT. NHPT, PHPT, and controls have similar lumbar spine and femoral neck BMD. NHPT and controls had a similar radial BMD, while patients with PHPT had a lower radial BMD than both patients with NHPT (P = .031) and controls (P < .05). Using the control group as the reference, after adjustment for interacting factors, there was no increase in risk of moderate-severe VF in NHPT (odds ratio [OR] 1.04, 95% confidence interval [CI] 0.25-4.55), while PHPT had an increased risk (OR 3.81,95% CI 1.15-15.12). Seventy-nine percent of NHPT and 59% of PHPT patients fulfilled the criteria for asymptomatic hyperparathyroidism.The biochemical phenotype of NHPT is intermediate between PHPT and controls. In contrast, the bone phenotype resembles controls with normal bone turnover, no significant BMD impairment, and no increased risk of VF.CONCLUSIONSThe biochemical phenotype of NHPT is intermediate between PHPT and controls. In contrast, the bone phenotype resembles controls with normal bone turnover, no significant BMD impairment, and no increased risk of VF. Abstract Context The clinical and radiological aspects of normocalcemic hyperparathyroidism (NHPT) are confounded by the differing methods used to rule out secondary hyperparathyroidism and by the small sample size. Objective To assess the clinical, biochemical, and radiological profile of NHPT compared with primary hyperparathyroidism (PHPT) and control subjects Design Multicentric cross-sectional study Setting Outpatient clinic Patients 47 NHPT, 41 PHPT, and 39 age- and sex-matched control subjects. Main Outcome Measures Calcium metabolism and bone turnover markers (BTMs). Lumbar spine, total hip, femoral neck, one-third distal radius bone mineral density (BMD). Morphometric vertebral fracture (VF) assessed by dual-energy X-ray absorptiometry. Results NHPT patients had significantly higher parathyroid hormone, 25(OH)-vitamin D levels and lower calcium × phosphorus product than controls (P < .001). Compared with PHPT, the NHPT group had significantly higher 25(OH) vitamin D levels (P = .016). NHPT had BTM levels similar to controls and PHPT. NHPT, PHPT, and controls have similar lumbar spine and femoral neck BMD. NHPT and controls had a similar radial BMD, while patients with PHPT had a lower radial BMD than both patients with NHPT (P = .031) and controls (P < .05). Using the control group as the reference, after adjustment for interacting factors, there was no increase in risk of moderate–severe VF in NHPT (odds ratio [OR] 1.04, 95% confidence interval [CI] 0.25-4.55), while PHPT had an increased risk (OR 3.81,95% CI 1.15-15.12). Seventy-nine percent of NHPT and 59% of PHPT patients fulfilled the criteria for asymptomatic hyperparathyroidism. Conclusions The biochemical phenotype of NHPT is intermediate between PHPT and controls. In contrast, the bone phenotype resembles controls with normal bone turnover, no significant BMD impairment, and no increased risk of VF. |
Author | Santonati, Assunta Lelli, Diana Bilezikian, John P Maggi, Daria Pedone, Claudio Naciu, Anda Mihaela Napoli, Nicola Tabacco, Gaia Manfrini, Silvia D’Onofrio, Luca Casini, Alessandro Cesareo, Roberto Briganti, Silvia Irina Pozzilli, Paolo Palermo, Andrea Castellitto, Domenico Falcone, Stefania Fabbri, Andrea |
AuthorAffiliation | Unit of Endocrinology and Diabetes, University Campus Bio-Medico, Rome, Italy Unit of Endocrinology and Metabolic Diseases, CTO A. Alesini Hospital, University Tor Vergata, Rome, Italy Department of Endocrinology, San Giovanni Addolorata Hospital, Rome, Italy Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy UOS Malattie Metaboliche, Santa Maria Goretti Hospital, Latina, Italy Unit of Geriatric, University Campus Bio-Medico, Rome, Italy Department of Medicine, Division of Endocrinology, College of Physicians & Surgeons, Columbia University, New York, NY, USA |
AuthorAffiliation_xml | – name: Unit of Endocrinology and Diabetes, University Campus Bio-Medico, Rome, Italy Unit of Endocrinology and Metabolic Diseases, CTO A. Alesini Hospital, University Tor Vergata, Rome, Italy Department of Endocrinology, San Giovanni Addolorata Hospital, Rome, Italy Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy UOS Malattie Metaboliche, Santa Maria Goretti Hospital, Latina, Italy Unit of Geriatric, University Campus Bio-Medico, Rome, Italy Department of Medicine, Division of Endocrinology, College of Physicians & Surgeons, Columbia University, New York, NY, USA |
Author_xml | – sequence: 1 givenname: Andrea surname: Palermo fullname: Palermo, Andrea organization: Unit of Endocrinology and Diabetes, University Campus Bio-Medico, Rome, Italy – sequence: 2 givenname: Anda Mihaela surname: Naciu fullname: Naciu, Anda Mihaela organization: Unit of Endocrinology and Diabetes, University Campus Bio-Medico, Rome, Italy – sequence: 3 givenname: Gaia orcidid: 0000-0002-6808-0700 surname: Tabacco fullname: Tabacco, Gaia email: g.tabacco@unicampus.it organization: Unit of Endocrinology and Diabetes, University Campus Bio-Medico, Rome, Italy – sequence: 4 givenname: Stefania surname: Falcone fullname: Falcone, Stefania organization: Unit of Endocrinology and Metabolic Diseases, CTO A. Alesini Hospital, University Tor Vergata, Rome, Italy – sequence: 5 givenname: Assunta surname: Santonati fullname: Santonati, Assunta organization: Department of Endocrinology, San Giovanni Addolorata Hospital, Rome, Italy – sequence: 6 givenname: Daria surname: Maggi fullname: Maggi, Daria organization: Unit of Endocrinology and Diabetes, University Campus Bio-Medico, Rome, Italy – sequence: 7 givenname: Luca surname: D’Onofrio fullname: D’Onofrio, Luca organization: Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy – sequence: 8 givenname: Silvia Irina surname: Briganti fullname: Briganti, Silvia Irina organization: Unit of Endocrinology and Diabetes, University Campus Bio-Medico, Rome, Italy – sequence: 9 givenname: Domenico surname: Castellitto fullname: Castellitto, Domenico organization: UOS Malattie Metaboliche, Santa Maria Goretti Hospital, Latina, Italy – sequence: 10 givenname: Alessandro surname: Casini fullname: Casini, Alessandro organization: UOS Malattie Metaboliche, Santa Maria Goretti Hospital, Latina, Italy – sequence: 11 givenname: Claudio surname: Pedone fullname: Pedone, Claudio organization: Geriatric Unit, University Campus Bio-Medico, Rome, Italy – sequence: 12 givenname: Diana surname: Lelli fullname: Lelli, Diana organization: Geriatric Unit, University Campus Bio-Medico, Rome, Italy – sequence: 13 givenname: Andrea surname: Fabbri fullname: Fabbri, Andrea organization: Unit of Endocrinology and Metabolic Diseases, CTO A. Alesini Hospital, University Tor Vergata, Rome, Italy – sequence: 14 givenname: John P surname: Bilezikian fullname: Bilezikian, John P organization: Department of Medicine, Division of Endocrinology, College of Physicians & Surgeons, Columbia University, New York, New York – sequence: 15 givenname: Nicola surname: Napoli fullname: Napoli, Nicola organization: Unit of Endocrinology and Diabetes, University Campus Bio-Medico, Rome, Italy – sequence: 16 givenname: Paolo orcidid: 0000-0001-5090-636X surname: Pozzilli fullname: Pozzilli, Paolo organization: Unit of Endocrinology and Diabetes, University Campus Bio-Medico, Rome, Italy – sequence: 17 givenname: Silvia surname: Manfrini fullname: Manfrini, Silvia organization: Unit of Endocrinology and Diabetes, University Campus Bio-Medico, Rome, Italy – sequence: 18 givenname: Roberto surname: Cesareo fullname: Cesareo, Roberto organization: UOS Malattie Metaboliche, Santa Maria Goretti Hospital, Latina, Italy |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32271382$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkEtr3DAURkVISCaPbZbFywbqRK-JpGUztE0htKWk0EVAXMvXGbWy5Ug2Yf59PXiyCYSuhO79zidxjsl-Fzsk5JzRS8YZvXLBd9he1Y8ATMk9smBGLkvFjNonC0o5K43iv4_Icc5_KGVSLsUhORKcKyY0X5CH1VTgHYQPxY2Pbo3tfIGuLn5C7WOIj9tJ8SPFxgcsYlN8i6mN08xtw9PCt5A2xe2mx9RDgmG9SdHXPren5KCBkPFsd56QX58_3a9uy7vvX76uPt6VTiguS6WM1ooh07WWrFJglgZF1dSuAacdVOAkkzUH0Ti-5NxUyA1VBqcdu5ZGnJD3c2-f4tOIebCtzw5DgA7jmC0XWk8uhKZT9N0uOlYt1raff29fjEwBOQdcijknbKzzAww-dkMCHyyjdivezuLtTvyEXb7CXprfBPgMPMcwYMp_w_iMya4RwrB-G7qYoTj2_3vgH5HnqRI |
CitedBy_id | crossref_primary_10_1007_s12020_021_02845_4 crossref_primary_10_3390_jcm13216325 crossref_primary_10_1016_j_mcna_2021_05_017 crossref_primary_10_1210_jendso_bvad013 crossref_primary_10_1007_s11154_020_09614_0 crossref_primary_10_22141_2224_0721_17_5_2021_241515 crossref_primary_10_3803_EnM_2021_1061 crossref_primary_10_33145_2304_8336_2024_29_44_66 crossref_primary_10_4158_EP_2020_0405 crossref_primary_10_1007_s11154_024_09899_5 crossref_primary_10_1016_j_eprac_2023_12_004 crossref_primary_10_1016_j_eprac_2021_04_884 crossref_primary_10_1002_jbm4_10391 crossref_primary_10_1210_clinem_dgad256 crossref_primary_10_1002_hed_26861 crossref_primary_10_23736_S1824_4785_23_03510_0 crossref_primary_10_3346_jkms_2022_37_e99 crossref_primary_10_1177_2042018821995370 crossref_primary_10_3389_fendo_2024_1428640 crossref_primary_10_1016_j_amjsurg_2024_03_007 crossref_primary_10_1093_jbmrpl_ziae074 crossref_primary_10_3389_fmicb_2023_1124945 crossref_primary_10_7759_cureus_64988 crossref_primary_10_20945_2359_4292_2023_0315 crossref_primary_10_1210_clinem_dgae659 crossref_primary_10_1007_s40618_020_01269_7 crossref_primary_10_1210_clinem_dgae239 crossref_primary_10_1007_s00405_021_06953_9 crossref_primary_10_1007_s13304_021_01108_1 crossref_primary_10_1007_s00198_023_06669_y crossref_primary_10_1007_s12020_023_03491_8 crossref_primary_10_1210_clinem_dgab240 crossref_primary_10_20945_2359_3997000000557 crossref_primary_10_20945_2359_3997000000556 crossref_primary_10_1002_jbmr_4679 crossref_primary_10_1007_s40619_023_01263_0 crossref_primary_10_1177_20406223211015965 crossref_primary_10_3390_pathogens12020184 crossref_primary_10_1007_s12020_023_03476_7 crossref_primary_10_3390_ijms222312975 crossref_primary_10_1007_s12020_020_02545_5 crossref_primary_10_1007_s12262_022_03420_5 |
Cites_doi | 10.1210/jc.2003-031014 10.1530/EC-15-0030 10.1590/S0004-27302011000500003 10.1530/eje.1.02225 10.1016/S0039-6060(97)90357-3 10.1210/jc.2013-1300 10.1007/s12020-012-9694-z 10.1159/000502578 10.1007/s00198-014-3000-2 10.1155/2012/128352 10.1210/jc.2007-1215 10.1210/jc.2002-021404 10.1007/s00198-005-2010-5 10.1210/jc.2014-1414 10.1111/cen.12819 10.1210/jc.2008-1763 10.4158/EP151055.OR 10.1210/jc.2014-1413 10.1002/jbmr.5650080915 10.1210/jc.2008-1758 10.1016/j.amjmed.2004.06.037 10.1210/jc.2006-2802 10.1056/NEJM196605262742105 10.1007/s00774-015-0673-3 10.1016/j.jocd.2012.12.001 10.1530/EJE-13-0305 10.1007/s42000-018-0069-6 10.1007/s00268-018-4512-2 10.1038/nrdp.2016.33 10.7326/0003-4819-130-6-199903160-00002 10.1210/jc.2014-1415 10.1056/NEJM199910213411701 10.1210/jc.2013-1518 10.1111/j.1365-2796.2004.01422.x 10.4081/reumatismo.2016.870 10.1007/s00223-010-9454-0 10.1016/S0140-6736(17)31430-7 10.1097/MED.0000000000000198 |
ContentType | Journal Article |
Copyright | Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2020 Copyright © Oxford University Press 2015 Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. |
Copyright_xml | – notice: Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2020 – notice: Copyright © Oxford University Press 2015 – notice: Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1210/clinem/dgaa174 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1945-7197 |
EndPage | e2616 |
ExternalDocumentID | 32271382 10_1210_clinem_dgaa174 10.1210/clinem/dgaa174 |
Genre | Journal Article |
GroupedDBID | --- -~X .55 .GJ .XZ 08P 0R~ 18M 1TH 29K 2WC 34G 354 39C 3O- 3V. 4.4 48X 53G 5GY 5RS 5YH 8F7 AABZA AACZT AAIMJ AAJQQ AAKAS AAPGJ AAPQZ AAPXW AAQQT AARHZ AAUAY AAUQX AAVAP AAWDT AAWTL AAYJJ ABBLC ABJNI ABLJU ABMNT ABNHQ ABOCM ABPMR ABPPZ ABPQP ABPTD ABQNK ABSAR ABWST ABXVV ACFRR ACGFO ACGFS ACPRK ACUTJ ACYHN ACZBC ADBBV ADGKP ADGZP ADHKW ADQBN ADRTK ADVEK ADZCM AELWJ AEMDU AENEX AENZO AERZD AETBJ AEWNT AFCHL AFFNX AFFZL AFGWE AFOFC AFRAH AFXAL AFYAG AGINJ AGKRT AGMDO AGQXC AGUTN AHMBA AI. AJEEA ALMA_UNASSIGNED_HOLDINGS APIBT APJGH AQDSO AQKUS ARIXL ASPBG ATGXG AVNTJ AVWKF AZFZN BAWUL BAYMD BCRHZ BENPR BEYMZ BPHCQ BSWAC BTRTY BVXVI C45 CDBKE CS3 D-I DAKXR DIK E3Z EBS EIHJH EJD EMOBN ENERS F5P FECEO FEDTE FHSFR FLUFQ FOEOM FOTVD FQBLK G8K GAUVT GJXCC GX1 H13 HVGLF HZ~ H~9 IAO IHR INH J5H KBUDW KOP KQ8 KSI KSN L7B M5~ MBLQV MHKGH MJL N4W N9A NLBLG NOMLY NOYVH NVLIB O9- OAUYM OBH OCB ODMLO OFXIZ OGEVE OHH OJZSN OK1 OPAEJ OVD OVIDX P2P P6G PQQKQ PROAC REU ROX ROZ TEORI TJX TLC TMA TR2 TWZ VH1 VVN W8F WHG WOQ X52 X7M YBU YFH YHG YOC YSK ZGI ZXP ZY1 ~02 ~H1 7X7 88E 8FI 8FJ ABDFA ABEJV ABGNP ABUWG ABVGC ABXZS ADNBA AEMQT AEOTA AFKRA AGORE AHGBF AHMMS AJBYB ALXQX CCPQU FYUFA HMCUK ITC M1P NU- PHGZM PHGZT PSQYO UKHRP AAYXX AEHZK CITATION PJZUB PPXIY PUEGO CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c3724-7798871e18d841b7a959e3bfdcfac8cabac414d2a3fc25229be29079e8ca16493 |
ISSN | 0021-972X 1945-7197 |
IngestDate | Sat Sep 27 19:54:40 EDT 2025 Mon Jul 21 06:08:11 EDT 2025 Thu Apr 24 23:07:07 EDT 2025 Wed Oct 01 01:54:22 EDT 2025 Fri May 16 03:56:34 EDT 2025 Wed Aug 28 03:18:41 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | hypercalcemia normocalcemic calcium PTH Hyperparathyroidism |
Language | English |
License | This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c3724-7798871e18d841b7a959e3bfdcfac8cabac414d2a3fc25229be29079e8ca16493 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-5090-636X 0000-0002-6808-0700 |
PMID | 32271382 |
PQID | 2388002380 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_2388002380 pubmed_primary_32271382 crossref_citationtrail_10_1210_clinem_dgaa174 crossref_primary_10_1210_clinem_dgaa174 wolterskluwer_health_10_1210_clinem_dgaa174 oup_primary_10_1210_clinem_dgaa174 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2020-07-01 |
PublicationDateYYYYMMDD | 2020-07-01 |
PublicationDate_xml | – month: 07 year: 2020 text: 2020-07-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | US |
PublicationPlace_xml | – name: US – name: United States |
PublicationTitle | The journal of clinical endocrinology and metabolism |
PublicationTitleAlternate | J Clin Endocrinol Metab |
PublicationYear | 2020 |
Publisher | Oxford University Press Copyright Oxford University Press |
Publisher_xml | – name: Oxford University Press – name: Copyright Oxford University Press |
References | Eastell (2021122116122941000_CIT0009) 2014; 99 Silverberg (2021122116122941000_CIT0012) 2003; 88 Tordjman (2021122116122941000_CIT0016) 2004; 117 Anastasilakis (2021122116122941000_CIT0011) 2019; 18 Díaz-Soto (2021122116122941000_CIT0032) 2016; 22 Pawlowska (2021122116122941000_CIT0036) 2015; 22 Bilezikian (2021122116122941000_CIT0021) 2018; 391 Kontogeorgos (2021122116122941000_CIT0028) 2015; 83 Levey (2021122116122941000_CIT0022) 1999; 130 Tuna (2021122116122941000_CIT0035) 2016; 34 Díaz-Soto (2021122116122941000_CIT0030) 2016; 48 Bilezikian (2021122116122941000_CIT0001) 2016; 2 Eastell (2021122116122941000_CIT0008) 2009; 94 Cesareo (2021122116122941000_CIT0018) 2015; 26 Cusano (2021122116122941000_CIT0014) 2013; 16 Cope (2021122116122941000_CIT0003) 1966; 274 Bilezikian (2021122116122941000_CIT0006) 2005; 257 Bilezikian (2021122116122941000_CIT0017) 2014; 99 Calcium calculator IOF (2021122116122941000_CIT0020) García-Martín (2021122116122941000_CIT0015) 2012; 42 Genant (2021122116122941000_CIT0024) 1993; 8 Vignali (2021122116122941000_CIT0027) 2015; 4 Amaral (2021122116122941000_CIT0034) 2012; 2012 Kiriakopoulos (2021122116122941000_CIT0033) 2018; 42 Rossini (2021122116122941000_CIT0019) 2016; 68 Silverberg (2021122116122941000_CIT0005) 1999; 341 Lemos (2021122116122941000_CIT0041) 2019;44(5):1189-1195 Rubin (2021122116122941000_CIT0004) 2008; 93 Lundgren (2021122116122941000_CIT0026) 1997; 121 Maruani (2021122116122941000_CIT0013) 2003; 88 Eller-Vainicher (2021122116122941000_CIT0039) 2013; 169 Schousboe (2021122116122941000_CIT0023) 2006; 17 Silverberg (2021122116122941000_CIT0002) 2014; 99 Koumakis (2021122116122941000_CIT0037) 2013; 98 Marques (2021122116122941000_CIT0029) 2011; 55 Bilezikian (2021122116122941000_CIT0007) 2009; 94 Cusano (2021122116122941000_CIT0010) 2013; 98 Cohen (2021122116122941000_CIT0025) 1988 De Geronimo (2021122116122941000_CIT0040) 2006; 155 Lowe (2021122116122941000_CIT0031) 2007; 92 Rejnmark (2021122116122941000_CIT0038) 2011; 88 |
References_xml | – volume: 88 start-page: 5348 issue: 11 year: 2003 ident: 2021122116122941000_CIT0012 article-title: “Incipient” primary hyperparathyroidism: a “forme fruste” of an old disease publication-title: J Clin Endocrinol Metab. doi: 10.1210/jc.2003-031014 – volume: 4 start-page: 172 issue: 3 year: 2015 ident: 2021122116122941000_CIT0027 article-title: Normocalcemic primary hyperparathyroidism: a survey in a small village of Southern Italy publication-title: Endocr Connect. doi: 10.1530/EC-15-0030 – volume: 55 start-page: 314 issue: 5 year: 2011 ident: 2021122116122941000_CIT0029 article-title: Normocalcemic primary hyperparathyroidism in clinical practice: an indolent condition or a silent threat? publication-title: Arq Bras Endocrinol Metabol. doi: 10.1590/S0004-27302011000500003 – volume: 155 start-page: 415 issue: 3 year: 2006 ident: 2021122116122941000_CIT0040 article-title: The risk of fractures in postmenopausal women with primary hyperparathyroidism publication-title: Eur J Endocrinol. doi: 10.1530/eje.1.02225 – volume: 121 start-page: 287 issue: 3 year: 1997 ident: 2021122116122941000_CIT0026 article-title: Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women publication-title: Surgery. doi: 10.1016/S0039-6060(97)90357-3 – volume: 98 start-page: 2734 issue: 7 year: 2013 ident: 2021122116122941000_CIT0010 article-title: Normocalcemic hyperparathyroidism and hypoparathyroidism in two community-based nonreferral populations publication-title: J Clin Endocrinol Metab. doi: 10.1210/jc.2013-1300 – volume: 42 start-page: 764 issue: 3 year: 2012 ident: 2021122116122941000_CIT0015 article-title: Normocalcemic primary hyperparathyroidism: one-year follow-up in one hundred postmenopausal women publication-title: Endocrine. doi: 10.1007/s12020-012-9694-z – year: 2019;44(5):1189-1195 ident: 2021122116122941000_CIT0041 article-title: High rate of occult urolithiasis in normocalcemic primary hyperparathyroidism publication-title: Kidney Blood Press. Res. doi: 10.1159/000502578 – volume: 26 start-page: 1295 issue: 4 year: 2015 ident: 2021122116122941000_CIT0018 article-title: Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism publication-title: Osteoporos Int. doi: 10.1007/s00198-014-3000-2 – volume: 2012 start-page: 128352 year: 2012 ident: 2021122116122941000_CIT0034 article-title: Normocalcemic versus hypercalcemic primary hyperparathyroidism: more stone than bone? publication-title: J Osteoporos. doi: 10.1155/2012/128352 – volume: 93 start-page: 3462 issue: 9 year: 2008 ident: 2021122116122941000_CIT0004 article-title: The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years publication-title: J Clin Endocrinol Metab. doi: 10.1210/jc.2007-1215 – volume: 88 start-page: 4641 issue: 10 year: 2003 ident: 2021122116122941000_CIT0013 article-title: Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone publication-title: J Clin Endocrinol Metab. doi: 10.1210/jc.2002-021404 – volume: 17 start-page: 281 issue: 2 year: 2006 ident: 2021122116122941000_CIT0023 article-title: Reliability and accuracy of vertebral fracture assessment with densitometry compared to radiography in clinical practice publication-title: Osteoporos Int. doi: 10.1007/s00198-005-2010-5 – volume: 48 start-page: 163 issue: 3 year: 2016 ident: 2021122116122941000_CIT0030 article-title: Clinical expression of calcium sensing receptor polymorphism (A986S) in normocalcemic and asymptomatic hyperparathyroidism publication-title: Horm Metab Res. – volume: 99 start-page: 3570 issue: 10 year: 2014 ident: 2021122116122941000_CIT0009 article-title: Diagnosis of asymptomatic primary hyperparathyroidism: Proceedings of the Fourth International Workshop publication-title: J Clin Endocrinol Metab. doi: 10.1210/jc.2014-1414 – volume: 83 start-page: 277 issue: 2 year: 2015 ident: 2021122116122941000_CIT0028 article-title: Normocalcaemic, vitamin D-sufficient hyperparathyroidism - high prevalence and low morbidity in the general population: A long-term follow-up study, the WHO MONICA project, Gothenburg, Sweden publication-title: Clin Endocrinol (Oxf). doi: 10.1111/cen.12819 – ident: 2021122116122941000_CIT0020 – volume: 94 start-page: 335 issue: 2 year: 2009 ident: 2021122116122941000_CIT0007 article-title: Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop publication-title: J Clin Endocrinol Metab. doi: 10.1210/jc.2008-1763 – volume: 22 start-page: 703 issue: 6 year: 2016 ident: 2021122116122941000_CIT0032 article-title: Trabecular bone score in patients with normocalcemic hyperparathyroidism publication-title: Endocr Pract. doi: 10.4158/EP151055.OR – volume: 99 start-page: 3561 issue: 10 year: 2014 ident: 2021122116122941000_CIT0017 article-title: Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop publication-title: J Clin Endocrinol Metab. doi: 10.1210/jc.2014-1413 – volume: 8 start-page: 1137 issue: 9 year: 1993 ident: 2021122116122941000_CIT0024 article-title: Vertebral fracture assessment using a semiquantitative technique publication-title: J Bone Miner Res. doi: 10.1002/jbmr.5650080915 – volume: 94 start-page: 340 issue: 2 year: 2009 ident: 2021122116122941000_CIT0008 article-title: Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop publication-title: J Clin Endocrinol Metab. doi: 10.1210/jc.2008-1758 – volume: 117 start-page: 861 issue: 11 year: 2004 ident: 2021122116122941000_CIT0016 article-title: Characterization of normocalcemic primary hyperparathyroidism publication-title: Am J Med. doi: 10.1016/j.amjmed.2004.06.037 – volume: 92 start-page: 3001 issue: 8 year: 2007 ident: 2021122116122941000_CIT0031 article-title: Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype publication-title: J Clin Endocrinol Metab. doi: 10.1210/jc.2006-2802 – volume: 274 start-page: 1174 issue: 21 year: 1966 ident: 2021122116122941000_CIT0003 article-title: The study of hyperparathyroidism at the Massachusetts General Hospital publication-title: N Engl J Med. doi: 10.1056/NEJM196605262742105 – volume: 34 start-page: 331 issue: 3 year: 2016 ident: 2021122116122941000_CIT0035 article-title: Normocalcemic hyperparathyroidism is associated with complications similar to those of hypercalcemic hyperparathyroidism publication-title: J Bone Miner Metab. doi: 10.1007/s00774-015-0673-3 – volume: 16 start-page: 33 issue: 1 year: 2013 ident: 2021122116122941000_CIT0014 article-title: Normocalcemic primary hyperparathyroidism publication-title: J Clin Densitom. doi: 10.1016/j.jocd.2012.12.001 – volume: 169 start-page: 155 issue: 2 year: 2013 ident: 2021122116122941000_CIT0039 article-title: Bone quality, as measured by trabecular bone score, in patients with primary hyperparathyroidism publication-title: Eur J Endocrinol. doi: 10.1530/EJE-13-0305 – volume: 18 start-page: 65 issue: 1 year: 2019 ident: 2021122116122941000_CIT0011 article-title: Asymptomatic and normocalcemic hyperparathyroidism, the silent attack: a combo-endocrinology overview publication-title: Hormones (Athens). doi: 10.1007/s42000-018-0069-6 – volume: 42 start-page: 992 issue: 4 year: 2018 ident: 2021122116122941000_CIT0033 article-title: Classic primary hyperparathyroidism versus normocalcemic and normohormonal variants: do they really differ? publication-title: World J Surg. doi: 10.1007/s00268-018-4512-2 – volume: 2 start-page: 16033 year: 2016 ident: 2021122116122941000_CIT0001 article-title: Primary hyperparathyroidism publication-title: Nat Rev Dis Primers. doi: 10.1038/nrdp.2016.33 – volume: 130 start-page: 461 issue: 6 year: 1999 ident: 2021122116122941000_CIT0022 article-title: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group publication-title: Ann Intern Med. doi: 10.7326/0003-4819-130-6-199903160-00002 – volume: 99 start-page: 3580 issue: 10 year: 2014 ident: 2021122116122941000_CIT0002 article-title: Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop publication-title: J Clin Endocrinol Metab. doi: 10.1210/jc.2014-1415 – start-page: 1 volume-title: The concept of Power analysis in Statistical Power Analysis for the Behavioral Sciences year: 1988 ident: 2021122116122941000_CIT0025 – volume: 341 start-page: 1249 issue: 17 year: 1999 ident: 2021122116122941000_CIT0005 article-title: A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery publication-title: N Engl J Med. doi: 10.1056/NEJM199910213411701 – volume: 98 start-page: 3213 issue: 8 year: 2013 ident: 2021122116122941000_CIT0037 article-title: Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism publication-title: J Clin Endocrinol Metab. doi: 10.1210/jc.2013-1518 – volume: 257 start-page: 6 issue: 1 year: 2005 ident: 2021122116122941000_CIT0006 article-title: Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features publication-title: J Intern Med. doi: 10.1111/j.1365-2796.2004.01422.x – volume: 68 start-page: 1 issue: 1 year: 2016 ident: 2021122116122941000_CIT0019 article-title: Guidelines for the diagnosis, prevention and management of osteoporosis publication-title: Reumatismo doi: 10.4081/reumatismo.2016.870 – volume: 88 start-page: 238 issue: 3 year: 2011 ident: 2021122116122941000_CIT0038 article-title: Increased fracture risk in normocalcemic postmenopausal women with high parathyroid hormone levels: a 16-year follow-up study publication-title: Calcif Tissue Int. doi: 10.1007/s00223-010-9454-0 – volume: 391 start-page: 168 issue: 10116 year: 2018 ident: 2021122116122941000_CIT0021 article-title: Hyperparathyroidism publication-title: Lancet. doi: 10.1016/S0140-6736(17)31430-7 – volume: 22 start-page: 413 issue: 6 year: 2015 ident: 2021122116122941000_CIT0036 article-title: An overview of normocalcemic primary hyperparathyroidism publication-title: Curr Opin Endocrinol Diabetes Obes. doi: 10.1097/MED.0000000000000198 |
SSID | ssj0014453 |
Score | 2.5199752 |
Snippet | Abstract
Context
The clinical and radiological aspects of normocalcemic hyperparathyroidism (NHPT) are confounded by the differing methods used to rule out... The clinical and radiological aspects of normocalcemic hyperparathyroidism (NHPT) are confounded by the differing methods used to rule out secondary... |
SourceID | proquest pubmed crossref wolterskluwer oup |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | e2609 |
SubjectTerms | Absorptiometry, Photon Aged Biomarkers - blood Bone Density - physiology Calcium - blood Cross-Sectional Studies Female Femur Neck - diagnostic imaging Humans Hyperparathyroidism, Primary - blood Hyperparathyroidism, Primary - diagnostic imaging Lumbar Vertebrae - diagnostic imaging Male Middle Aged Parathyroid Hormone - blood Vitamin D - analogs & derivatives Vitamin D - blood |
Title | Clinical, Biochemical, and Radiological Profile of Normocalcemic Primary Hyperparathyroidism |
URI | https://www.ncbi.nlm.nih.gov/pubmed/32271382 https://www.proquest.com/docview/2388002380 |
Volume | 105 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1945-7197 dateEnd: 20241002 omitProxy: true ssIdentifier: ssj0014453 issn: 0021-972X databaseCode: DIK dateStart: 19970101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1945-7197 dateEnd: 20241002 omitProxy: true ssIdentifier: ssj0014453 issn: 0021-972X databaseCode: GX1 dateStart: 19960101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1945-7197 dateEnd: 20211231 omitProxy: true ssIdentifier: ssj0014453 issn: 0021-972X databaseCode: 7X7 dateStart: 20170101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1945-7197 dateEnd: 20211231 omitProxy: true ssIdentifier: ssj0014453 issn: 0021-972X databaseCode: BENPR dateStart: 20170101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLa6TkIghLhTLlNASDxsGXHixPEjoJUKqdWEOqkPSJFjOxDYEtS1QvDL-Hkcx46bQCcGL1Hjy0mT8-Ucn_hcEHquQZCEmPixkMonvFA-By3rC5kEkjKBcRPlOp0lkxPybhEvBoOfHa-l9So_FD-2xpX8D1ehDfiqo2T_gbOOKDTAb-AvHIHDcLwUj21ST7NxUOraV2ftaRN3yGXpZNuxKc7dfCGAdapWYcI4xtt8ExOwSJdNJvBP35d1Kdvcgp83eOqkmXARlaqSNUieapPL6UytAFmn7XxTpAUUQO0cKJ0qmHFRrm0z35-W2oPfdc55zoVoZr3lpWsec72HpqyLWsEr22U_XYCd2rq5bkIJsM9oU08dlJGRwIzEPsXGadeJ6CDuYJF2BK4Ce4x1tDecm9jNP1QD2LbAT_10FLxpY_mRc2wKBPWzcP-mHZ3PoraWgEZmKGR2_g7aDWmShEO0-_podvze7WARYjOg2lu0CUN1xJSh8NJS6C2IekGWHVvnGrr-rdbuE-dfmuiJzhpofhPdsMaL98og8RYaqOo2ujK17hl30IcWkAdeB44HHqDC64LRs2D06sLrgdGzYPS2gPEuOhkfzd9MfFu-wxcRDQnYbQw0GFY4lSnBOeUsZirKCykKLlKhMUQwkSGPChGCGcByFbKAMgV9YMSz6B4aVoCnB8gTCsyYCBcJ45gEsILCQiQc9LRIo1QWZIT89hlmwua21yVWTrPtXBuhF278V3NjF458Biz566CnLccykM56y41Xql6fZ6HOtaSXxcEI3TesdLRAlVKdAXSE9nu8zUwE9AXXenjpv_4IXd28dI_RcLVcqyewgl7le2iHLuiehewvfAbP7w |
linkProvider | ProQuest |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical%2C+Biochemical%2C+and+Radiological+Profile+of+Normocalcemic+Primary+Hyperparathyroidism&rft.jtitle=The+journal+of+clinical+endocrinology+and+metabolism&rft.au=Palermo%2C+Andrea&rft.au=Naciu%2C+Anda+Mihaela&rft.au=Tabacco%2C+Gaia&rft.au=Falcone%2C+Stefania&rft.date=2020-07-01&rft.issn=0021-972X&rft.eissn=1945-7197&rft.volume=105&rft.issue=7&rft.spage=e2609&rft.epage=e2616&rft_id=info:doi/10.1210%2Fclinem%2Fdgaa174&rft.externalDBID=n%2Fa&rft.externalDocID=10_1210_clinem_dgaa174 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-972X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-972X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-972X&client=summon |